Charge variant native mass spectrometry benefits mass precision and dynamic range of monoclonal antibody intact mass analysis. Issue 8 (17th November 2018)

• Record Type: Journal Article
• Authors: Bailey, Aaron O.; Han, Guanghui; Phung, Wilson; Gazis, Paul; Sutton, Jennifer; Josephs, Jonathan L.; Sandoval, Wendy
• Is Part Of: MAbs. Volume 10:Issue 8(2018)
• Page Start: 1214
• Page End: 1225
• Publication Date: 2018-11-17
• Subjects: charge variant -- charge variant mass spectrometry -- ion exchange -- weak cation exchange -- native mass spectrometry -- high resolution -- deamidation -- intact mass -- Orbitrap; Monoclonal antibodies -- Therapeutic use -- Periodicals; Monoclonal antibodies -- Periodicals; Antibodies, Monoclonal -- Periodicals; 616.0798
• DOI: 10.1080/19420862.2018.1521131
• Languages: English
• ISSNs: 1942-0862

Abstract

ABSTRACT: The preponderance and diversity of charge variants in therapeutic monoclonal antibodies has implications for antibody efficacy and degradation. Understanding the extent and impact of minor antibody variants is of great interest, and it is also a critical regulatory requirement. Traditionally, a combination of approaches is used to characterize antibody charge heterogeneity, including ion exchange chromatography and independent mass spectrometric variant site mapping after proteolytic digestion. Here, we describe charge variant native mass spectrometry (CVMS), an integrated native ion exchange mass spectrometry-based charge variant analytical approach that delivers detailed molecular information in a single, semi-automated analysis. We utilized pure volatile salt mobile phases over a pH gradient that effectively separated variants based on minimal differences in isoelectric point. Characterization of variants such as deamidation, which are traditionally unattainable by intact mass due to their minimal molecular weight differences, were measured unambiguously by mass and retention time to allow confident MS1 identification. We demonstrate that efficient chromatographic separation allows introduction of the purified forms of the charge variant isoforms into the Orbitrap mass spectrometer. Our CVMS method allows confident assignment of intact monoclonal antibody isoforms of similar mass and relative abundance measurements across three orders of magnitude dynamic range.